UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 275

Sortiert nach

Efficacy of Bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis

The Journal of urology, 2017-09, Vol.198 (3), p.503-510

2017

Volltextzugriff (PDF)

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

European urology, 2020-10, Vol.78 (4), p.533-537

2020

Volltextzugriff (PDF)

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers

European urology, 2013-01, Vol.63 (1), p.4-15

2013

Volltextzugriff (PDF)

Definition, Incidence, Risk Factors, and Prevention of Paralytic Ileus Following Radical Cystectomy: A Systematic Review

European urology, 2013-10, Vol.64 (4), p.588-597

2013

Volltextzugriff (PDF)

Role of immunotherapy in bacillus Calmette–Guérin-unresponsive non–muscle invasive bladder cancer

Urologic oncology, 2018-03, Vol.36 (3), p.103-108

2018

Volltextzugriff (PDF)

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer

World journal of urology, 2019-01, Vol.37 (1), p.3-13

2019

Volltextzugriff (PDF)

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model

Experimental gerontology, 2018-05, Vol.105, p.146-154

2018

Volltextzugriff (PDF)

A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3)

Frontiers in oncology, 2024-01, Vol.13, p.1157880-1157880

2024

Volltextzugriff (PDF)

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Cancer medicine (Malden, MA), 2021-03, Vol.10 (6), p.2137-2152

2021

Volltextzugriff (PDF)

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

Oncoimmunology, 2019-08, Vol.8 (8), p.1614857

2019

Volltextzugriff (PDF)

The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

European urology, 2014-08, Vol.66 (2), p.253-262

2014

Volltextzugriff (PDF)

What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up

Urologic oncology, 2014-02, Vol.32 (2), p.128-134

2014

Volltextzugriff (PDF)

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Future oncology (London, England), 2019-05, Vol.15 (15), p.1683-1695

2019

Volltextzugriff (PDF)

Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma

Investigative and clinical urology, 2023-11, Vol.64 (6), p.561-571

2023

Volltextzugriff (PDF)

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation

Oncoimmunology, 2021-01, Vol.10 (1), p.2006529-2006529

2021

Volltextzugriff (PDF)

Novel Therapeutic Approaches for Recurrent Nonmuscle Invasive Bladder Cancer

Urologic clinics of North America, 2015-05, Vol.42 (2), p.159-168

2015

Volltextzugriff (PDF)

Clinical outcomes and patterns of population‐based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4273-4282

2022

Volltextzugriff (PDF)

KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8970-8980

2023

Volltextzugriff (PDF)

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis

European urology oncology, 2020-06, Vol.3 (3), p.318-340

2020

Volltextzugriff (PDF)

Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration

Journal of obesity, 2018-01, Vol.2018, p.9247864-10

2018

Volltextzugriff (PDF)

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002051

2021

Volltextzugriff (PDF)

A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression

Virology journal, 2017-08, Vol.14 (1), p.149-149, Article 149

2017

Volltextzugriff (PDF)

Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond

Vaccine, 2021-12, Vol.39 (50), p.7332-7340

2021

Volltextzugriff (PDF)

First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin

European urology, 2022-12, Vol.82 (6), p.602-610

2022

Volltextzugriff (PDF)

What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy?

European urology, 2019-04, Vol.75 (4), p.612-614

2019

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(160)

Publikationsform

Artikel
(274)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(98)
Urology
(76)
Humans
(69)
Urology & Nephrology
(63)
Bladder Cancer
(48)
Oncology
(45)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Male
(28)
Nephrology. Urinary Tract Diseases
(27)
Urinary Bladder Neoplasms - Pathology
(24)
Female
(21)
Tumors
(20)
Tumors Of The Urinary System
(18)
Urinary Tract. Prostate Gland
(18)
Immunotherapy
(16)
Urinary Bladder Neoplasms - Drug Therapy
(16)
Urinary Bladder Neoplasms - Therapy
(16)
Cancer
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(106)
European Urology
(27)
The journal Of Urology/the journal Of Urology
(18)
Urologic Oncology
(14)
The Journal Of Immunology
(9)
Bladder Cancer
(8)
Cancer
(8)
Urology
(8)
Cancer Research
(7)
Journal Of Clinical Oncology
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Efficacy of Bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers

Definition, Incidence, Risk Factors, and Prevention of Paralytic Ileus Following Radical Cystectomy: A Systematic Review

Role of immunotherapy in bacillus Calmette–Guérin-unresponsive non–muscle invasive bladder cancer

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model

A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3)

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation

Novel Therapeutic Approaches for Recurrent Nonmuscle Invasive Bladder Cancer

Clinical outcomes and patterns of population‐based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database

KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis

Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression

Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond

First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin

What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy?

Aktive Filter

Suchergebnisse filtern